about
Pharmacodynamic and therapeutic investigation of focused ultrasound-induced blood-brain barrier opening for enhanced temozolomide delivery in glioma treatment.Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study.Combining microbubbles and ultrasound for drug delivery to brain tumors: current progress and overview.Current concepts in stereotactic radiosurgery - a neurosurgical and radiooncological point of view.A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant gliomaLocal delivery of rapamycin: a toxicity and efficacy study in an experimental malignant glioma model in ratsTemozolomide and radiotherapy versus radiotherapy alone in high grade gliomas: a very long term comparative study and literature review.Safety and efficacy of high-dose chemotherapy with autologous stem cell transplantation for patients with malignant astrocytomas.Sustained radiographic and clinical response in patient with bifrontal recurrent glioblastoma multiforme with intracerebral infusion of the recombinant targeted toxin TP-38: case studyEffective radiovirotherapy for malignant gliomas by using oncolytic measles virus strains encoding the sodium iodide symporter (MV-NIS).Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.The outcomes of concomitant chemoradiotherapy followed by adjuvant chemotherapy with temozolomide for newly diagnosed high grade gliomas : the preliminary results of single center prospective study.Paediatric and adult malignant glioma: close relatives or distant cousins?Elderly patients with glioblastoma: the treatment challenge.Irradiation differentially affects substratum-dependent survival, adhesion, and invasion of glioblastoma cell lines.Effects of resveratrol and methoxyamine on the radiosensitivity of iododeoxyuridine in U87MG glioblastoma cell line.Downregulation of Id2 increases chemosensitivity of glioma.Inhibition of Akt kinase signalling and activation of Forkhead are indispensable for upregulation of FasL expression in apoptosis of glioma cells.Efficacy of vincristine and etoposide with escalating cyclophosphamide in poor-prognosis pediatric brain tumors.Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study.Post-operative sequential chemo-radiotherapy in high-grade cerebral gliomas with fotemustine.Temozolomide treatment in glioma--experiences in two university hospitals in Finland.Evaluation of apoptosis induced by exposure to antineoplastic drugs in peripheral blood lymphocytes of nurses.Controlled release of liposome-encapsulated temozolomide for brain tumour treatment by convection-enhanced delivery.Astrocytic tumors in children: treatment results from a single institution.A phase I study of cranial radiation therapy with concomitant continuous infusion paclitaxel in children with brain tumors.Prediction of the anti-glioma therapeutic effects of temozolomide through in vivo molecular imaging of MMP expression.Dynamic susceptibility contrast perfusion weighted imaging in grading of nonenhancing astrocytomas.Aspects on the survival of patients with glioblastoma and the origin and histology of oligodendrogliomas.Does high-dose carmustine increase overall survival in supratentorial high-grade malignant glioma? An EBMT retrospective study.[Malignant gliomas--radiotherapy].
P2860
Q27322329-F452B9A5-A335-4C5C-B734-979053AB7190Q30416228-872927C8-36D2-4E3F-82C9-E0A94A8ACA5FQ30442623-8A2DEB0D-21D3-4C8C-B240-84382E3A7D41Q30467551-ADAE13E2-EDE6-4013-836F-9D8F5255599FQ34547574-7ACE83DC-692E-4339-8753-E5CEEFBCE58AQ35085333-7004D663-0FCC-48BC-A770-261FE2C9DB81Q35177942-0E0979A0-45D9-42D6-974F-8C2F3D5DE1F0Q35771162-750A8380-3A17-47DD-A597-53D101B547E7Q35799893-3F142CA8-5F5F-4DE3-B97E-1E055A059562Q35892063-83B5DB82-5D87-44AE-BBAF-B416EF0AEDC8Q36668246-9BC807D1-058A-4BA7-B612-BFB7ECC7559AQ36986280-E2EE310C-0AE4-495B-9717-B9A4AFB15DD4Q38013990-A72E85E0-E749-448A-B232-1D26BD17B55BQ38151772-17835F24-D19A-454F-B466-37714F3EEE1AQ38303751-20B5F1D7-121F-4268-BBD7-16DD2FA25452Q38805341-D5C93488-D70E-4A57-AAA3-D56D6B8557D3Q38899685-1297FC30-6A0F-426B-948B-4DBF66F6E0AFQ40623335-24C18104-3353-4760-B900-0A8C44E1E1B4Q42785394-7EA90640-837E-425F-9E6C-81F005D1DA87Q43286608-573970DF-530F-4307-B2FF-47AB33C33970Q45031146-2AF847EB-470C-48B5-98B7-128E705E9691Q45061240-A62D66E9-82E2-4481-9FB8-2DEE7799F019Q47749421-A905CF59-0ABC-40B1-A512-5575964440E6Q47984087-0BD785A4-7516-46A7-B694-A0BD12257DB4Q48389827-2A135284-CC90-4DF7-99CF-E72710783CEEQ48783521-BDA78E12-14C8-4CF2-B4DD-62E6F7BF9533Q55456656-6283B4E7-4127-41E0-A9AA-9FCDD6EF39D3Q55463816-4D7096E9-50B4-4D67-9289-29870C67F02FQ55465608-795BF8D0-1004-4AFF-BCD0-66C1EF36C602Q55468593-9E7C71F2-90F8-41B5-93CE-36FC4A1AFB00Q55469529-138F59AA-A55D-4A45-AC0B-992EF3CA68DE
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Chemotherapy for high-grade gliomas.
@ast
Chemotherapy for high-grade gliomas.
@en
type
label
Chemotherapy for high-grade gliomas.
@ast
Chemotherapy for high-grade gliomas.
@en
prefLabel
Chemotherapy for high-grade gliomas.
@ast
Chemotherapy for high-grade gliomas.
@en
P2860
P921
P356
P1476
Chemotherapy for high-grade gliomas.
@en
P2093
P2860
P2888
P304
P356
10.1054/BJOC.1999.1075
P407
P577
2000-04-01T00:00:00Z
P5875
P6179
1011384908